FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

879883007: Inebilizumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3993487010 Inebilizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3993488017 Inebilizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3993487010 Inebilizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3993488017 Inebilizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Inebilizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Inebilizumab-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Inebilizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Inebilizumab only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Inebilizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Inebilizumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Inebilizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Inebilizumab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Inebilizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely inebilizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Inebilizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely inebilizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Inebilizumab Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start